Clinical Trials Browser

Phase 2 × INDUSTRY × Zoledronic Acid × Clear all

NCT01951586 2021-10-25

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Phase 2 Completed

226 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT04325776 2020-10-12

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Phase 2 Unknown

Bone Metastatic Non-small Cell Lung Cancer

NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Phase 2 Completed

43 enrolled 10 charts

Bone Diseases, Breast Neoplasms

NCT00247650 2017-03-01

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Phase 2 Completed

Breast Neoplasms

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Phase 2 Completed

139 enrolled 23 charts

BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT00258765 2010-04-26

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.

Phase 2 Terminated

Prostatic Neoplasms

NCT00172068 2009-12-23

MRD-1

Phase 2 Terminated

Neoplasm, Residual

NCT00636740 2009-02-20

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

Phase 2 Completed

Prostatic Neoplasms

NCT00072930 2008-01-15

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms